• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

温度对蛋白质溶液黏度和蛋白质-蛋白质相互作用的影响:高黏度蛋白质溶液成因的新视角。

Temperature Dependence of Protein Solution Viscosity and Protein-Protein Interactions: Insights into the Origins of High-Viscosity Protein Solutions.

机构信息

Department of Chemical & Biomolecular Engineering, University of Delaware, Newark, Delaware 19716, United States.

Drug Product Development, Amgen Inc., Thousand Oaks, California 91320, United States.

出版信息

Mol Pharm. 2020 Dec 7;17(12):4473-4482. doi: 10.1021/acs.molpharmaceut.0c00552. Epub 2020 Nov 10.

DOI:10.1021/acs.molpharmaceut.0c00552
PMID:33170708
Abstract

Protein solution viscosity (η) as a function of temperature was measured at a series of protein concentrations under a range of formulation conditions for two monoclonal antibodies (MAbs) and a globular protein (aCgn). Based on theoretical arguments, a strong temperature dependence for protein-protein interactions (PPI) indicates highly anisotropic, short-ranged attractions that could lead to higher solution viscosities. The semi-empirical Ross-Minton model was used to determine the apparent intrinsic viscosity, shape, and "crowding" factors for each protein as a function of temperature and formulation conditions. The apparent intrinsic viscosity was independent of temperature for aCgn, while a slight decrease with increasing temperature was observed for the MAbs. The temperature dependence of solution viscosity was analyzed using the Andrade-Eyring equation to determine the effective activation energy of viscous flow (). While values were different for each protein, they were independent of formulation conditions for a given protein. PPI were quantified via the osmotic second virial coefficient () and the protein diffusion interaction parameter () as a function of temperature under the same formulation conditions as the viscosity measurements. Net interactions ranged from strongly attractive to repulsive by changing formulation pH and ionic strength for each protein. Overall, larger activation energies for PPI corresponded to larger activation energies for η, and those were predictive of the highest η values at higher protein concentrations.

摘要

在两种单克隆抗体(MAb)和一种球形蛋白(aCgn)的一系列制剂条件下,测量了一系列蛋白浓度下的蛋白溶液黏度(η)与温度的关系。基于理论论证,蛋白-蛋白相互作用(PPI)的强温度依赖性表明存在高度各向异性、短程吸引力,这可能导致溶液黏度升高。采用半经验的 Ross-Minton 模型来确定每种蛋白的表观特性黏度、形状和“拥挤”因子随温度和制剂条件的变化。aCgn 的表观特性黏度与温度无关,而 MAb 的表观特性黏度则随温度略有下降。通过 Andrade-Eyring 方程分析溶液黏度的温度依赖性,以确定粘性流的有效活化能(Ea)。虽然每个蛋白的 Ea 值不同,但在给定蛋白的相同制剂条件下,Ea 值是独立的。通过渗透压第二维里系数(B22)和蛋白扩散相互作用参数(D)来量化 PPI,这些参数在与黏度测量相同的制剂条件下随温度而变化。通过改变每种蛋白的制剂 pH 值和离子强度,可以使净相互作用从强吸引变为强排斥。总体而言,PPI 的较大活化能对应于 η 的较大活化能,且那些可以预测在较高蛋白浓度下达到最高 η 值的情况。

相似文献

1
Temperature Dependence of Protein Solution Viscosity and Protein-Protein Interactions: Insights into the Origins of High-Viscosity Protein Solutions.温度对蛋白质溶液黏度和蛋白质-蛋白质相互作用的影响:高黏度蛋白质溶液成因的新视角。
Mol Pharm. 2020 Dec 7;17(12):4473-4482. doi: 10.1021/acs.molpharmaceut.0c00552. Epub 2020 Nov 10.
2
How Well Do Low- and High-Concentration Protein Interactions Predict Solution Viscosities of Monoclonal Antibodies?低浓度和高浓度蛋白相互作用在多大程度上可以预测单克隆抗体的溶液黏度?
J Pharm Sci. 2019 Jan;108(1):142-154. doi: 10.1016/j.xphs.2018.07.007. Epub 2018 Jul 12.
3
Studying Excipient Modulated Physical Stability and Viscosity of Monoclonal Antibody Formulations Using Small-Angle Scattering.利用小角散射研究赋形剂调节的单克隆抗体制剂的物理稳定性和黏度。
Mol Pharm. 2019 Oct 7;16(10):4319-4338. doi: 10.1021/acs.molpharmaceut.9b00687. Epub 2019 Sep 24.
4
Flow Activation Energy of High-Concentration Monoclonal Antibody Solutions and Protein-Protein Interactions Influenced by NaCl and Sucrose.高浓度单克隆抗体溶液的流动激活能和 NaCl 与蔗糖影响的蛋白质-蛋白质相互作用。
Mol Pharm. 2024 Sep 2;21(9):4553-4564. doi: 10.1021/acs.molpharmaceut.4c00460. Epub 2024 Aug 20.
5
Viscosity of high concentration protein formulations of monoclonal antibodies of the IgG1 and IgG4 subclass - prediction of viscosity through protein-protein interaction measurements.高浓度单克隆抗体 IgG1 和 IgG4 亚型蛋白制剂的黏度 - 通过蛋白-蛋白相互作用测量预测黏度。
Eur J Pharm Sci. 2013 Jun 14;49(3):400-10. doi: 10.1016/j.ejps.2013.04.019. Epub 2013 Apr 26.
6
Towards an improved prediction of concentrated antibody solution viscosity using the Huggins coefficient.利用哈金斯系数提高浓抗体溶液黏度预测精度。
J Colloid Interface Sci. 2022 Feb;607(Pt 2):1813-1824. doi: 10.1016/j.jcis.2021.08.191. Epub 2021 Sep 4.
7
Electrostatically Mediated Protein-Protein Interactions for Monoclonal Antibodies: A Combined Experimental and Coarse-Grained Molecular Modeling Approach.静电介导的单克隆抗体蛋白-蛋白相互作用:一种组合实验和粗粒分子建模方法。
J Pharm Sci. 2019 Jan;108(1):120-132. doi: 10.1016/j.xphs.2018.11.004. Epub 2018 Nov 9.
8
The role of electrostatics in protein-protein interactions of a monoclonal antibody.静电在单克隆抗体蛋白质-蛋白质相互作用中的作用。
Mol Pharm. 2014 Jul 7;11(7):2475-89. doi: 10.1021/mp5002334. Epub 2014 Jun 18.
9
Factors affecting the viscosity in high concentration solutions of different monoclonal antibodies.不同单克隆抗体高浓度溶液黏度的影响因素。
J Pharm Sci. 2010 Dec;99(12):4812-29. doi: 10.1002/jps.22190.
10
Viscosities and Protein Interactions of Bispecific Antibodies and Their Monospecific Mixtures.双特异性抗体及其单克隆混合物的黏度和蛋白相互作用。
Mol Pharm. 2018 Oct 1;15(10):4745-4755. doi: 10.1021/acs.molpharmaceut.8b00706. Epub 2018 Sep 12.

引用本文的文献

1
Rapid Solidification of Plant Latices from Driven by a Sudden Decrease in Hydrostatic Pressure.由静水压力突然降低驱动的植物乳胶快速凝固
Plants (Basel). 2025 Mar 4;14(5):798. doi: 10.3390/plants14050798.
2
Rapid Development of High Concentration Protein Formulation Driven by High-Throughput Technologies.高通量技术驱动高浓度蛋白质制剂的快速发展
Pharm Res. 2025 Jan;42(1):151-171. doi: 10.1007/s11095-024-03801-3. Epub 2025 Jan 17.
3
Hybrid Mass Spectrometry Applied across the Production of Antibody Biotherapeutics.混合质谱在抗体生物治疗药物生产中的应用
J Am Soc Mass Spectrom. 2025 Jan 1;36(1):44-57. doi: 10.1021/jasms.4c00253. Epub 2024 Nov 21.
4
Diffusion and Viscosity in Mixed Protein Solutions.混合蛋白溶液中的扩散和黏度。
J Phys Chem B. 2024 Nov 28;128(47):11676-11693. doi: 10.1021/acs.jpcb.4c06877. Epub 2024 Nov 19.
5
Thioflavin T─a Reporter of Microviscosity in Protein Aggregation Process: The Study Case of α-Synuclein.硫黄素 T─一种蛋白质聚集过程中微粘度的报告者:以α-突触核蛋白为例。
J Phys Chem Lett. 2024 Jun 27;15(25):6685-6690. doi: 10.1021/acs.jpclett.4c00699. Epub 2024 Jun 20.
6
Antibody association in solution: cluster distributions and mechanisms.溶液中的抗体缔合:聚集体分布和机制。
MAbs. 2024 Jan-Dec;16(1):2339582. doi: 10.1080/19420862.2024.2339582. Epub 2024 Apr 26.
7
The Relationship between Protein-Protein Interactions and Liquid-Liquid Phase Separation for Monoclonal Antibodies.单克隆抗体中蛋白质-蛋白质相互作用与液-液相分离的关系。
Mol Pharm. 2023 May 1;20(5):2662-2674. doi: 10.1021/acs.molpharmaceut.3c00090. Epub 2023 Apr 11.
8
US FDA-approved therapeutic antibodies with high-concentration formulation: summaries and perspectives.美国食品药品监督管理局批准的高浓度制剂治疗性抗体:概述与展望。
Antib Ther. 2021 Nov 18;4(4):262-272. doi: 10.1093/abt/tbab027. eCollection 2021 Oct.